The Uromigos Episode 67: The Third Debate—PD1/VEGF Versus PD1/CTLA4 for Front-Line Renal Cancer

Drs. David McDermott and Brian Rini debate treatment options (PD1/VEGF versus PD1/CTLA4) in front-line renal cancer. It’s hard to identify any winners from this podcast.